Neuraxis (NRXS) Earnings Date & Reports

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRXS is expected to report earnings to fall 36.84% to -11 cents per share on November 17

Q3'26

Est.

$-0.12

Q2'26

Missed

by $0.03

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.06

Q3'25

Est.

$-0.24

The last earnings report on August 11 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 13.21K shares outstanding, the current market capitalization sits at 92.93M.

View a ticker or compare two or three

NRXS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for NRXS